Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population.

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

In Vitro Functional Analysis of 24 Novel Cyp2c19 Variants Recently Found in the Chinese Han Population

Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms in Vitro

Functional Characterization of Cyp2d6 Novel Allelic Variants Identified in the Chinese Han Population

Identification and Functional Assessment of Eight CYP3A4 Allelic Variants 39-46 Detected in the Chinese Han Population

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

In Vitro and in Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population

In Vitro Functional Characterization of 37 CYP2C9 Allelic Isoforms Found in Chinese Han Population.

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C972-75 in the Chinese Han population

Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants

Genetic variations of human CYP2D6 in the Chinese Han population.

Genetic Variants, Haplotype Determination, and Function of Novel Alleles of CYP2B6 in a Han Chinese Population

Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population.

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro

Systematic Screening for Polymorphisms in the CYP3A4 Gene in the Chinese Population.

Genetic Polymorphisms and Phenotypic Analysis of Drug-Metabolizing Enzyme CYP2C19 in a Li Chinese Population.

Assessment of 25 CYP2D6 alleles found in the Chinese population on propafenone metabolism in vitro.

Genetic Polymorphisms Of The Drug-Metabolizing Enzyme Cytochrome P450 2a6 In A Tibetan Chinese Population

Functional Characterization of Wild-Type and 24 Cyp2d6 Allelic Variants on Gefitinib Metabolism in Vitro

Identification of CYP2D6 Impaired Functional Alleles in Mexican Americans.